Beacon Financial Group’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$373K Buy
1,571
+17
+1% +$3.53K 0.03% 286
2026
Q1
$328K Sell
1,554
-2
-0.1% -$431 0.03% 283
2025
Q4
$320K Buy
1,556
+15
+1% +$2.82K 0.03% 284
2025
Q3
$242K Sell
1,541
-33
-2% -$5.1K 0.02% 319
2025
Q2
$264K Buy
1,574
+107
+7% +$15.9K 0.03% 302
2025
Q1
$202K Buy
+1,467
New +$187K 0.02% 326
2024
Q1
Sell
-7,367
Closed -$743K 322
2023
Q4
$743K Sell
7,367
-291
-4% -$28.9K 0.09% 173
2023
Q3
$669K Sell
7,658
-536
-7% -$48.5K 0.1% 160
2023
Q2
$770K Sell
8,194
-743
-8% -$62.8K 0.1% 149
2023
Q1
$712K Buy
+8,937
New +$674K 0.1% 155
2022
Q4
Sell
-12,005
Closed -$814K 227
2022
Q3
$814K Buy
12,005
+1
+0% +$63 0.13% 146
2022
Q2
$649K Sell
12,004
-93
-0.8% -$5.29K 0.1% 168
2022
Q1
$688K Buy
+12,097
New +$648K 0.09% 168

Other funds holding CAH

Beacon Financial Group's CAH Position: Q2 2026 in Review

Beacon Financial Group increased its Cardinal Health (CAH) stake by 1.1% in Q2 2026, buying an estimated $3.53K and bringing the position to 1,571 shares worth $373K. The position accounts for 0.03% of the portfolio, ranked #286.

Beacon Financial Group first reported a position in CAH in Q1 2022 and has held it in 13 quarters since. The position peaked at $814K in Q3 2022. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Beacon Financial Group held 1,571 shares of Cardinal Health worth $373K as of Q2 2026.
  • Beacon Financial Group bought 17 Cardinal Health shares in Q2 2026, an estimated $3.53K.
  • Cardinal Health made up 0.03% of Beacon Financial Group's portfolio in Q2 2026, its #286 holding.
  • Beacon Financial Group first reported a position in Cardinal Health in Q1 2022 and has held it in 13 quarters since.
  • Beacon Financial Group's Cardinal Health position peaked at $814K in Q3 2022.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Beacon Financial Group's 13F filing for Q2 2026, filed 16 Jul 2026.